IRTC
IRTC
NASDAQ · Health Care

Irhythm Holdings Inc

$121.79
+3.10 (+2.61%)
As of Mar 25, 9:54 PM ET ·
Financial Highlights (FY 2026)
Revenue
754.44M
Net Income
-44,984,931
Gross Margin
70.6%
Profit Margin
-6.0%
Rev Growth
+22.1%
D/E Ratio
4.25
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 70.6% 70.6% 36.4% 36.4%
Operating Margin -7.7% -6.9% 12.1% 15.0%
Profit Margin -6.0% -5.7% 12.0% 14.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 754.44M 618.14M 1.48B 1.53B
Gross Profit 532.41M 436.22M 539.48M 555.34M
Operating Income -57,940,840 -42,725,732 179.99M 228.68M
Net Income -44,984,931 -33,172,009 177.25M 225.68M
Gross Margin 70.6% 70.6% 36.4% 36.4%
Operating Margin -7.7% -6.9% 12.1% 15.0%
Profit Margin -6.0% -5.7% 12.0% 14.8%
Rev Growth +22.1% +22.1% +2.2% -3.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.52B 1.52B 326.12M 362.93M
Total Equity 357.74M 357.74M 2.53B 2.36B
D/E Ratio 4.25 4.25 0.13 0.15
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -31,528,232 -24,540,614 234.45M 287.53M
Free Cash Flow 120.95M 142.43M